Osteopore (ASX:OSX) signed a deal with Swiss Stock Exchange-listed holding firm DiethelmKellerSiberHegner (DKSH) to market and sell Osteopore's off-the-shelf orthopedic products in Singapore, according to a Wednesday filing with the Australian bourse.

As per the multi-year deal, DKSH will promote the company's bone loss treatment products in Singapore, the filing said.

The deal comes after receiving market approvals in March.

Osteopore's shares were up almost 3% in recent Wednesday trade.

Price (AUD): $0.04, Change: $+0.001, Percent Change: +2.56%